(Q36877987)

English

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings

scientific article published on August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings (English)

1 reference

Europe PubMed Central

16 August 2017

anti-retroviral agent

0 references

misclassification

1 reference

based on heuristic

inferred from title

object named as

Philip Chan

9

0 references

object named as

Joseph Hogan

11

0 references

author name string

Rami Kantor

1

1 reference

Europe PubMed Central

16 August 2017

Lameck Diero

2

1 reference

Europe PubMed Central

16 August 2017

Allison Delong

3

1 reference

Europe PubMed Central

16 August 2017

Lydia Kamle

4

1 reference

Europe PubMed Central

16 August 2017

Sarah Muyonga

5

1 reference

Europe PubMed Central

16 August 2017

Fidelis Mambo

6

1 reference

Europe PubMed Central

16 August 2017

Eunice Walumbe

7

1 reference

Europe PubMed Central

16 August 2017

Wilfred Emonyi

8

1 reference

Europe PubMed Central

16 August 2017

E Jane Carter

10

1 reference

Europe PubMed Central

16 August 2017

Nathan Buziba

12

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

1 August 2009

1 reference

Europe PubMed Central

16 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

16 August 2017

49

1 reference

Europe PubMed Central

16 August 2017

3

1 reference

Europe PubMed Central

16 August 2017

454-462

1 reference

Europe PubMed Central

16 August 2017

Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

When to switch for antiretroviral treatment failure in resource-limited settings?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Impact of HIV-1 pol diversity on drug resistance and its clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Changing antiretroviral therapy in the setting of virologic relapse: review of the current literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

The prevalence of antiretroviral drug resistance in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Population-based hematologic and immunologic reference values for a healthy Ugandan population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

29 September 2017

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

27 June 2018

Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

27 June 2018

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

HIV viral load monitoring in resource-limited regions: optional or necessary?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Discordant immunological and virological responses to antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Relationship between CD4 count and CD4% in HIV-infected people.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 September 2018

Performance of Immunologic Responses in Predicting Viral Load Suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 December 2018

CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 December 2018

CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4859427

4 December 2018

National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19569972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19569972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral load testing in resource-limited settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/19569972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19569972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring antiretroviral failure in resource-poor settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/19569972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART

1 reference

https://pubmed.ncbi.nlm.nih.gov/19569972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

16 August 2017

release_czo6nmrvszeuja47kfmn6cgmui

1 reference

https://api.fatcat.wiki/v0/release/czo6nmrvszeuja47kfmn6cgmui

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36877987&oldid=2088076203"